Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity (Q51557810)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

author name string

E K Waters

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

publication date

30 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

Acta Biotheoretica

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

60

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

333-356

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

A competitive exclusion principle for pathogen virulence

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Sex in Australia: heterosexual experience and recent heterosexual encounters among a representative sample of adults.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

The roles of social domains, behavioral risk, health care resources, and chlamydia in spatial clusters of US cervical cancer mortality: not all the clusters are the same

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Prevalence of HPV infection among females in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Vaccination against multiple HPV types

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

The Competitive Exclusion Principle

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

A diffusive SI model with Allee effect and application to FIV.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Simple stochastic models and their power-law type behaviour.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Maximum likelihood estimation of the negative binomial dispersion parameter for highly overdispersed data, with applications to infectious diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of Subsequent Infection in Men

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV.

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Transmission dynamics of HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Cost-effectiveness of a potential vaccine for human papillomavirus

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

The 2001 Bethesda System: terminology for reporting results of cervical cytology

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Evaluating human papillomavirus vaccination programs

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Early Natural History of Incident, Type-Specific Human Papillomavirus Infections in Newly Sexually Active Young Women

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Competitive Exclusion in Gonorrhea Models and Other Sexually Transmitted Diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Competitive Exclusion and Coexistence of Multiple Strains in an SIS STD Model

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

A general framework for the aggregation model of coexistence

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

HPV infection in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Multiple Human Papillomavirus Infections: The Exception or the Rule?

1 reference

https://api.crossref.org/works/10.1007%2FS10441-012-9161-5

21 January 2018

Identifiers

10.1007/S10441-012-9161-5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/22752424

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51557810&oldid=2277141418"